BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 28155126)

  • 1. 60 years of Cimicifuga racemosa medicinal products : Clinical research milestones, current study findings and current development.
    Henneicke-von Zepelin HH
    Wien Med Wochenschr; 2017 May; 167(7-8):147-159. PubMed ID: 28155126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Cimicifuga racemosa, Hypericum perforatum and Agnus castus in the treatment of climacteric complaints: a systematic review.
    Laakmann E; Grajecki D; Doege K; zu Eulenburg C; Buhling KJ
    Gynecol Endocrinol; 2012 Sep; 28(9):703-9. PubMed ID: 22385322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of black cohosh (Cimicifuga racemosa) medicines for treatment of menopausal symptoms - comments on major statements of the Cochrane Collaboration report 2012 "black cohosh (Cimicifuga spp.) for menopausal symptoms (review)".
    Beer AM; Osmers R; Schnitker J; Bai W; Mueck AO; Meden H
    Gynecol Endocrinol; 2013 Dec; 29(12):1022-5. PubMed ID: 23992293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone.
    Bai W; Henneicke-von Zepelin HH; Wang S; Zheng S; Liu J; Zhang Z; Geng L; Hu L; Jiao C; Liske E
    Maturitas; 2007 Sep; 58(1):31-41. PubMed ID: 17587516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The non-estrogenic alternative for the treatment of climacteric complaints: Black cohosh (Cimicifuga or Actaea racemosa).
    Wuttke W; Jarry H; Haunschild J; Stecher G; Schuh M; Seidlova-Wuttke D
    J Steroid Biochem Mol Biol; 2014 Jan; 139():302-10. PubMed ID: 23459142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms - an update on the evidence.
    Castelo-Branco C; Gambacciani M; Cano A; Minkin MJ; Rachoń D; Ruan X; Beer AM; Schnitker J; Henneicke-von Zepelin HH; Pickartz S
    Climacteric; 2021 Apr; 24(2):109-119. PubMed ID: 33021111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of black cohosh (Actaea racemosa, Cimicifuga racemosa).
    Huntley A
    Expert Opin Drug Saf; 2004 Nov; 3(6):615-23. PubMed ID: 15500420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms.
    Osmers R; Friede M; Liske E; Schnitker J; Freudenstein J; Henneicke-von Zepelin HH
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1074-83. PubMed ID: 15863547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of Black cohosh (Actaea/Cimicifuga racemosa) in the treatment of vasomotor symptoms--review of clinical trials].
    Kanadys WM; Leszczyńska-Gorzelak B; Oleszczuk J
    Ginekol Pol; 2008 Apr; 79(4):287-96. PubMed ID: 18592868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit-risk profile of black cohosh (isopropanolic
    Ruan X; Mueck AO; Beer AM; Naser B; Pickartz S
    Climacteric; 2019 Aug; 22(4):339-347. PubMed ID: 30626212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055.
    Raus K; Brucker C; Gorkow C; Wuttke W
    Menopause; 2006; 13(4):678-91. PubMed ID: 16837890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a Cimicifuga racemosa extracts Ze 450 in the treatment of climacteric complaints--an observational study.
    Drewe J; Zimmermann C; Zahner C
    Phytomedicine; 2013 Jun; 20(8-9):659-66. PubMed ID: 23537746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacologic and clinical studies using Cimicifuga racemosa in climacteric complaints].
    Winterhoff H; Butterweck V; Jarry H; Wuttke W
    Wien Med Wochenschr; 2002; 152(15-16):360-3. PubMed ID: 12244879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Black cohosh (Actaea/Cimicifuga racemosa): review of the clinical data for safety and efficacy in menopausal symptoms.
    Mahady GB
    Treat Endocrinol; 2005; 4(3):177-84. PubMed ID: 15898823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers.
    Wuttke W; Seidlová-Wuttke D; Gorkow C
    Maturitas; 2003 Mar; 44 Suppl 1():S67-77. PubMed ID: 12609561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms.
    Reed S; Newton K; LaCroix A; Grothaus L
    Obstet Gynecol; 2005 Nov; 106(5 Pt 1):1111; author reply 1111-2. PubMed ID: 16260542
    [No Abstract]   [Full Text] [Related]  

  • 17. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial.
    Frei-Kleiner S; Schaffner W; Rahlfs VW; Bodmer Ch; Birkhäuser M
    Maturitas; 2005 Aug; 51(4):397-404. PubMed ID: 16039414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of black cohosh (Cimicifuga racemosa) and estrogen on metaphyseal fracture healing in the early stage of osteoporosis in ovariectomized rats.
    Kolios L; Schumann J; Sehmisch S; Rack T; Tezval M; Seidlova-Wuttke D; Frosch KH; Stuermer KM; Stuermer EK
    Planta Med; 2010 Jun; 76(9):850-7. PubMed ID: 20104444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints - a prospective observational study.
    Rostock M; Fischer J; Mumm A; Stammwitz U; Saller R; Bartsch HH
    Gynecol Endocrinol; 2011 Oct; 27(10):844-8. PubMed ID: 21231853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of
    Furtado Macruz C; Lima SMRR
    J Obstet Gynaecol; 2022 Oct; 42(7):3236-3240. PubMed ID: 35993523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.